RxDoctor Payments Data

Johnatan Mariano

Adult Health · North Richland Hills, TXNPI 1588053409

Payments from drug & device makers

$2,523in general payments, 2019–2025

Across 117 payments — averaging $21.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Scpharmaceuticals Inc.$337
  • Novartis$315
  • E.r. Squibb & Sons, L.L.C.$272
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$265
  • Merck$243
  • AstraZeneca$194
  • plus $897 from 18 others

What the payments were for

  • Food & beverage$2,523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,523 in reported general payments places this provider in the 80th percentile of 933 adult health providers in Texas.

See all adult health providers in Texas

Medicare billing

Part B allowed, 2024
$29,020
Medicare patients
149
Services billed
386

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban41$51,719
EntrestoSacubitril/Valsartan13$26,554
XareltoRivaroxaban24$22,498
Repatha SyringeEvolocumab11$8,002
Metoprolol Succinate150$1,437
Potassium Chloride38$1,423
Carvedilol126$1,129
Rosuvastatin Calcium99$984
Losartan Potassium76$732
Isosorbide Mononitrate ErIsosorbide Mononitrate67$671
Amlodipine Besylate120$619
Furosemide124$610
Valsartan28$527
Torsemide14$516
Lisinopril72$484

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$180$51,71941 claims
NovartisEntresto$315$26,55413 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 933 adult health providers in Texas.

Other adult health in North Richland Hills

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →